2.200
+4,76%
2026-10-16
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.0% | -12.3% | 1 / 3 | +46.4% | -1.10 pp | -0.43 pp | +14.7% | 0.19 | 8.84 | 329 | +46,4% | 4,4 | +11,0% | 8.84 | 10.96 | −19,4% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.200 (close price on 2026-10-16)EPS (TTM): 249,0
Financial charts
1.Revenue & growth
VND bn329Q2/26
1.Revenue & growth
VND bn329Q2/26
2.Profit & growth
VND bn4,39Q2/26
3.Profit mix (Penman)
VND bn14,9Q2/26
4.Margins & cost structure
%5.5%Q2/26
5.Returns & cash cycle
% · days40.0%Q2/26
6.Earnings quality & cash
VND bn5,09Q2/26
7.Asset structure
VND bn1.020Q2/26
8.Funding & debt health
VND bn · times1.020Q2/26
9.Revenue backlog
VND bn7,69Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %73Q2/26
Adjusted EPS growth, latest quarter
11.0%
Average adjusted EPS growth, 3 quarters
-12.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26